Literature DB >> 24052258

Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1).

Koichiro Mihara1, Rithwik Ramachandran, Bernard Renaux, Mahmoud Saifeddine, Morley D Hollenberg.   

Abstract

Neutrophil proteinases released at sites of inflammation can affect tissue function by either activating or disarming signal transduction mediated by proteinase-activated receptors (PARs). Because PAR1 is expressed at sites where abundant neutrophil infiltration occurs, we hypothesized that neutrophil-derived enzymes might also regulate PAR1 signaling. We report here that both neutrophil elastase and proteinase-3 cleave the human PAR1 N terminus at sites distinct from the thrombin cleavage site. This cleavage results in a disarming of thrombin-activated calcium signaling through PAR1. However, the distinct non-canonical tethered ligands unmasked by neutrophil elastase and proteinase-3, as well as synthetic peptides with sequences derived from these novel exposed tethered ligands, selectively stimulated PAR1-mediated mitogen-activated protein kinase activation. This signaling was blocked by pertussis toxin, implicating a Gαi-triggered signal pathway. We conclude that neutrophil proteinases trigger biased PAR1 signaling and we describe a novel set of tethered ligands that are distinct from the classical tethered ligand revealed by thrombin. We further demonstrate the function of this biased signaling in regulating endothelial cell barrier integrity.

Entities:  

Keywords:  Biased Signaling; Calcium Signaling; Endothelial Cell; G Protein-coupled Receptors (GPCR); Intracellular Trafficking; MAP Kinases (MAPKs); Neutrophil; Proteinase-activated Receptor; Thrombin

Mesh:

Substances:

Year:  2013        PMID: 24052258      PMCID: PMC3829148          DOI: 10.1074/jbc.M113.483123

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1.

Authors:  Joseph N McLaughlin; Lixin Shen; Michael Holinstat; Joshua D Brooks; Emmanuele Dibenedetto; Heidi E Hamm
Journal:  J Biol Chem       Date:  2005-05-04       Impact factor: 5.157

Review 2.  Neutrophil serine proteases: specific regulators of inflammation.

Authors:  Christine T N Pham
Journal:  Nat Rev Immunol       Date:  2006-07       Impact factor: 53.106

Review 3.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

4.  Proteinase-activated receptors, targets for kallikrein signaling.

Authors:  Katerina Oikonomopoulou; Kristina K Hansen; Mahmoud Saifeddine; Illa Tea; Michael Blaber; Sachiko I Blaber; Isobel Scarisbrick; Patricia Andrade-Gordon; Graeme S Cottrell; Nigel W Bunnett; Eleftherios P Diamandis; Morley D Hollenberg
Journal:  J Biol Chem       Date:  2006-08-02       Impact factor: 5.157

5.  Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents.

Authors:  Samuel Chackalamannil; Yan Xia; William J Greenlee; Martin Clasby; Darìo Doller; Hsingan Tsai; Theodros Asberom; Michael Czarniecki; Ho-Sam Ahn; George Boykow; Carolyn Foster; Jacqueline Agans-Fantuzzi; Matthew Bryant; Janice Lau; Madhu Chintala
Journal:  J Med Chem       Date:  2005-09-22       Impact factor: 7.446

6.  The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.

Authors:  Jong-Sup Bae; Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Blood       Date:  2007-09-06       Impact factor: 22.113

7.  Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells.

Authors:  J-S Bae; L Yang; A R Rezaie
Journal:  J Thromb Haemost       Date:  2008-02-12       Impact factor: 5.824

8.  Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia.

Authors:  Wolfgang Knecht; Graeme S Cottrell; Silvia Amadesi; Johanna Mohlin; Anita Skåregärde; Karin Gedda; Anders Peterson; Kevin Chapman; Morley D Hollenberg; Nathalie Vergnolle; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

9.  Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.

Authors:  Reto A Schuepbach; Clemens Feistritzer; Lawrence F Brass; Matthias Riewald
Journal:  Blood       Date:  2007-12-18       Impact factor: 22.113

10.  Proteolysis of the endothelial cell protein C receptor by neutrophil proteinase 3.

Authors:  A Villegas-Mendez; R Montes; L R Ambrose; A N Warrens; M Laffan; D A Lane
Journal:  J Thromb Haemost       Date:  2007-05       Impact factor: 5.824

View more
  45 in total

1.  Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.

Authors:  Peishen Zhao; TinaMarie Lieu; Nicholas Barlow; Silvia Sostegni; Silke Haerteis; Christoph Korbmacher; Wolfgang Liedtke; Nestor N Jimenez-Vargas; Stephen J Vanner; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

Review 2.  Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.

Authors:  M D Hollenberg; K Mihara; D Polley; J Y Suen; A Han; D P Fairlie; R Ramachandran
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Protease Activity in Vascular Disease.

Authors:  Megan A Slack; Scott M Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-25       Impact factor: 8.311

Review 4.  Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection.

Authors:  M D Hollenberg
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

Review 5.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

6.  Iterative Optimization of the Cyclic Peptide SFTI-1 Yields Potent Inhibitors of Neutrophil Proteinase 3.

Authors:  Sixin Tian; Joakim E Swedberg; Choi Yi Li; David J Craik; Simon J de Veer
Journal:  ACS Med Chem Lett       Date:  2019-07-19       Impact factor: 4.345

7.  Proteinase-activated receptors 1 and 2 and the regulation of porcine coronary artery contractility: a role for distinct tyrosine kinase pathways.

Authors:  Mahmoud El-Daly; Mahmoud Saifeddine; Koichiro Mihara; Rithwik Ramachandran; Christopher R Triggle; Morley D Hollenberg
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

8.  Protease-Activated Receptor 1 Deletion Causes Enhanced Osteoclastogenesis in Response to Inflammatory Signals through a Notch2-Dependent Mechanism.

Authors:  Sandra Jastrzebski; Judith Kalinowski; Sehwan Mun; Bongjin Shin; Naga Suresh Adapala; Christian E Jacome-Galarza; Faryal Mirza; H Leonardo Aguila; Hicham Drissi; Archana Sanjay; Ernesto Canalis; Sun-Kyeong Lee; Joseph A Lorenzo
Journal:  J Immunol       Date:  2019-05-20       Impact factor: 5.422

Review 9.  Role of the blood coagulation cascade in hepatic fibrosis.

Authors:  Asmita Pant; Anna K Kopec; James P Luyendyk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-03       Impact factor: 4.052

10.  Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder.

Authors:  WooJin Kim; Erin Zekas; Robert Lodge; Delia Susan-Resiga; Edwidge Marcinkiewicz; Rachid Essalmani; Koichiro Mihara; Rithwik Ramachandran; Eugene Asahchop; Benjamin Gelman; Éric A Cohen; Christopher Power; Morley D Hollenberg; Nabil G Seidah
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.